Literature DB >> 1740420

Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids.

K Bernstrom1, K Kayganich, R C Murphy, F A Fitzpatrick.   

Abstract

The different regioisomers of epoxyeicosatrienoic acids derived from cytochrome P-450 monooxygenase are readily esterified into phospholipids of mastocytoma cells. Incorporation of 14,15-epoxyeicosatrienoic acid was concentration-dependent, with Km = 1.1 microM and Vmax = 36 pmol/min/10(7) cells. Half-maximal incorporation occurred in 30 min, reaching a steady-state concentration of 470 pmol/10(6) cells. This was slightly lower than the values for arachidonic acid (665 pmol/10(6) cells) or 5-hydroxyeicosatetraenoic acid (554 pmol/10(6) cells). The distribution of 14,15-epoxyeicosatrienoic acid was preferential in the order phosphatidylethanolamine greater than phosphatidylcholine greater than phosphatidylinositol greater than phosphatidyl serine much greater than neutral lipids plus fatty acids. This contrasted with 5(S)-hydroxyeicosatetraenoic acid, which was distributed primarily into phosphatidylcholine. Fast atom bombardment/tandem mass spectrometry facilitated identification of molecular species containing epoxyeicosatrienoic acids without relying on radioisotopes. Phosphatidylethanolamine plasmalogens with 16:1 or 18:2 at the sn-1 position, or an 18:0 acyl group, and phosphatidylcholine with 16:0 alkyl ether or an acyl group at the sn-1 position incorporated all possible epoxyeicosatrienoic acid regioisomers. Under basal conditions, cells eliminated 14,15-cis-epoxyeicosatrienoic acid slowly with a half-life of 34.9 +/- 7 h. Cells stimulated with calcium ionophore A23187 eliminated 14,15-epoxyeicosatrienoic acid rapidly. It was notable that its rate of release from phosphatidylcholine and phosphatidylinositol exceeded that for arachidonic acid. A coenzyme A-independent transacylase also catalyzed the transfer of epoxyeicosatrienoic acids from mastocytoma cell membranes into 1-palmitoyl-2-lysophosphatidylcholine. The cellular incorporation, release, and distribution of epoxyeicosatrienoic acids is distinctive and contrasts with most other eicosanoids, suggesting that these compounds may have both autocoid and nonautocoid functions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740420

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  The physiology of developmental changes in BOLD functional imaging signals.

Authors:  Julia J Harris; Clare Reynell; David Attwell
Journal:  Dev Cogn Neurosci       Date:  2011-04-27       Impact factor: 6.464

2.  Mechanism of the sex difference in neuronal ischemic cell death.

Authors:  S L Fairbanks; J M Young; J W Nelson; C M Davis; I P Koerner; N J Alkayed
Journal:  Neuroscience       Date:  2012-05-26       Impact factor: 3.590

3.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

4.  Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes.

Authors:  Bora Inceoglu; Karen M Wagner; Jun Yang; Ahmed Bettaieb; Nils H Schebb; Sung Hee Hwang; Christophe Morisseau; Fawaz G Haj; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

5.  Acute Hypercapnia/Ischemia Alters the Esterification of Arachidonic Acid and Docosahexaenoic Acid Epoxide Metabolites in Rat Brain Neutral Lipids.

Authors:  Yurika Otoki; Adam H Metherel; Theresa Pedersen; Jun Yang; Bruce D Hammock; Richard P Bazinet; John W Newman; Ameer Y Taha
Journal:  Lipids       Date:  2019-11-06       Impact factor: 1.880

Review 6.  Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450.

Authors:  E H Oliw; J Bylund; C Herman
Journal:  Lipids       Date:  1996-10       Impact factor: 1.880

7.  Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.

Authors:  Karen Wagner; Bora Inceoglu; Hua Dong; Jun Yang; Sung Hee Hwang; Paul Jones; Christophe Morisseau; Bruce D Hammock
Journal:  Eur J Pharmacol       Date:  2012-12-28       Impact factor: 4.432

Review 8.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

9.  Impaired transactivation of the human CYP2J2 arachidonic acid epoxygenase gene in HepG2 cells subjected to nitrative stress.

Authors:  Pei H Cui; Andy C Lee; Fanfan Zhou; Michael Murray
Journal:  Br J Pharmacol       Date:  2010-02-24       Impact factor: 8.739

Review 10.  Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.

Authors:  Karen Wagner; Bora Inceoglu; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-10       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.